These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7901242)

  • 1. Pharmacology of terazosin: an alpha 1-selective blocker.
    Kyncl JJ
    J Clin Pharmacol; 1993 Sep; 33(9):878-83. PubMed ID: 7901242
    [No Abstract]   [Full Text] [Related]  

  • 2. 4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
    Patane MA; Scott AL; Broten TP; Chang RS; Ransom RW; DiSalvo J; Forray C; Bock MG
    J Med Chem; 1998 Apr; 41(8):1205-8. PubMed ID: 9548811
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin.
    Witte DG; Brune ME; Katwala SP; Milicic I; Kerwin JF; Hancock AA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):891-8. PubMed ID: 9262356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of intravenous and intracerebroventricular terazosin, prazosin and clonidine on spontaneous sympathetic outflow in rats].
    Yuki S; Hanazuka M; Watanabe T; Nishi H
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):225-33. PubMed ID: 2886411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers.
    Kang BC; Yang CQ; Rhee JE; Suh OK; Shin WG
    Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):371-7. PubMed ID: 12889528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical clinical pharmacology of antihypertensive drugs.
    Gifford RW
    Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic modelling of arterial haemodynamic effects of terazosin in healthy volunteers.
    Campanero MA; Sádaba B; Muñoz-Juarez MJ; Quetglas EG; Azanza JR
    Clin Drug Investig; 2008; 28(3):139-47. PubMed ID: 18266399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
    Sivkov AV; Apolikhin OI; Medvedev AA
    Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the pharmacokinetic-pharmacodynamic interaction between terazosin and finasteride.
    Samara EE; Hosmane B; Locke C; Eason C; Cavanaugh J; Granneman GR
    J Clin Pharmacol; 1996 Dec; 36(12):1169-78. PubMed ID: 9013375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-1 adrenergic receptor antagonist, terazosin, on cardiovascular functions in anaesthetised dogs.
    Sharma R; Ahuja VM; Fahim M
    Indian J Exp Biol; 2004 Dec; 42(12):1195-9. PubMed ID: 15623230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats.
    Ramage AG; Wyllie MG
    Eur J Pharmacol; 1995 Dec; 294(2-3):645-50. PubMed ID: 8750729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epinephrine stimulation of CNS alpha1-adrenoceptors in motor activity in mice.
    Stone EA; Grunewald GL; Lin Y; Ahsan R; Rosengarten H; Kramer HK; Quartermain D
    Synapse; 2003 Jul; 49(1):67-76. PubMed ID: 12710017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of food on the oral bioavailability of terazosin.
    McNeil JJ; Drummer OH; Raymond K; Conway EL; Louis WJ
    Br J Clin Pharmacol; 1991 Dec; 32(6):775-6. PubMed ID: 1685091
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of age on pharmacokinetics of and blood pressure responses to prazosin and terazosin.
    McNeil JJ; Drummer OH; Conway EL; Workman BS; Louis WJ
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):168-75. PubMed ID: 2441167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the alpha 1-adrenergic antagonists terazosin and phentolamine on prostatic adenoma and urethra in vitro.
    Alver JE; Mooppan UM; Kester RR; Gintautas J; Abadir AR; Kim H
    Proc West Pharmacol Soc; 1989; 32():317-25. PubMed ID: 2571162
    [No Abstract]   [Full Text] [Related]  

  • 16. Prazosin and phentolamine: comparative cardiovascular and autonomic profiles.
    Commarato MA; Langley AE; Dugan DH; Lattime EC; Smith RD; Tessman DK; Kaplan HR
    Clin Exp Hypertens (1978); 1978; 1(2):191-217. PubMed ID: 39713
    [No Abstract]   [Full Text] [Related]  

  • 17. alpha-Adrenoceptor subtypes mediating regional kidney blood flow responses to renal nerve stimulation.
    Eppel GA; Lee LL; Evans RG
    Auton Neurosci; 2004 May; 112(1-2):15-24. PubMed ID: 15233926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin.
    Meredith PA; Elliott HL; Kelman AW; Vincent J; Reid JL
    Xenobiotica; 1988 Jan; 18(1):123-9. PubMed ID: 2895548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension.
    Pasanisi F; Imperatore G; Vaccaro O; Iovine C; Ferrara LA
    Nutr Metab Cardiovasc Dis; 1999 Apr; 9(2):73-7. PubMed ID: 10726112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.